---
title: "Arvinas Holding Company (ARVN) Receives a Buy from Wells Fargo"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286235748.md"
description: "Wells Fargo analyst Derek Archila has maintained a Buy rating on Arvinas Holding Company (ARVN) with a price target of $15.00, while the stock closed at $9.66. The analyst consensus is a Moderate Buy with an average price target of $16.23, indicating a potential upside of 68.01%. Barclays also assigned a Buy rating with a $20.00 price target. Archila is a 5-star analyst with a 20.1% average return and a 53.67% success rate in the Healthcare sector."
datetime: "2026-05-13T09:37:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286235748.md)
  - [en](https://longbridge.com/en/news/286235748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286235748.md)
---

# Arvinas Holding Company (ARVN) Receives a Buy from Wells Fargo

In a report released on May 11, Derek Archila from Wells Fargo maintained a Buy rating on Arvinas Holding Company, with a price target of $15.00. The company’s shares closed yesterday at $9.66.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Archila is a 5-star analyst with an average return of 20.1% and a 53.67% success rate. Archila covers the Healthcare sector, focusing on stocks such as Rhythm Pharmaceuticals, Incyte, and Argenx Se.

Currently, the analyst consensus on Arvinas Holding Company is a Moderate Buy with an average price target of $16.23, which is a 68.01% upside from current levels. In a report released today, Barclays also assigned a Buy rating to the stock with a $20.00 price target.

### Related Stocks

- [ARVN.US](https://longbridge.com/en/quote/ARVN.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [RYTM.US](https://longbridge.com/en/quote/RYTM.US.md)
- [INCY.US](https://longbridge.com/en/quote/INCY.US.md)
- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [Arvinas Buy Rating Reiterated as Analyst Highlights Pipeline Optionality and VEPPANU Deal, Maintains $18 Price Target](https://longbridge.com/en/news/286287214.md)
- [These Analysts Increase Their Forecasts On Arvinas After Q1 Results](https://longbridge.com/en/news/286300592.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Insider Selling: Arvinas (NASDAQ:ARVN) CAO Sells 1,919 Shares of Stock](https://longbridge.com/en/news/286321834.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)